Industry Research Reports
Home > Reports > Chemical & Material > Cannabigerol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Cannabigerol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Chemical & Material
Published Date: 2026-01-08
Pages: 144 Pages
Report ld: 5589676
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cannabigerol Market Size(US$)
CAGR 2026-2032
8.7%
Market Size,2032
USD 292
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 177 million
Market Forecast in 2032(Value)
US$ 292 million
CAGR
8.7%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Cannabigerol was estimated to be worth US$ 164 million in 2025 and is projected to reach US$ 292 million, growing at a CAGR of 8.7% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cannabigerol cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Cannabigerol, or CBG, is a non-psychoactive cannabinoid that is one of the many chemical compounds found within the cannabis plant. It’s often referred to as the “stem cell” or “mother” of all cannabinoids because it serves as the precursor for the development of other major cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD). CBG is produced in the early stages of the cannabis plant’s growth, and as the plant matures, it undergoes enzymatic changes that convert CBG into other cannabinoids, making it a relatively rare compound in mature cannabis plants.
The global CBG market is expanding explosively, with the core driving force coming from the surge in demand for non-psychoactive cannabinoids in the medical and health consumption sectors. On the application side, the medical sector (anti-inflammatory, neurodegenerative disease treatment clinical research breakthroughs) accounts for the majority of revenue (55%), while skin care products (antioxidant, anti-acne effects) and functional foods (relieving anxiety, pain) have become the fastest growing segments; on the technical side, microbial fermentation methods are accelerating the replacement of traditional planting extraction with zero THC compliance and cost advantages. Regional markets are showing differentiation: North America (especially the United States) accounts for 60% of the global share based on mature regulations, followed by Europe to accelerate the process of medical legalization, while the Asia-Pacific region is limited by policies (China only allows exports) and growth lags, but emerging countries such as Thailand and Malaysia are gradually opening up medical imports to release incremental space. Future competition will focus on large-scale production of high-purity CBG crystals (>99%) and patented delivery technologies (such as nanoemulsification to improve bioavailability), but regulatory lags (such as FDA not approving CBG as a dietary supplement) and supply chain fluctuations remain key risk points.
This report provides a comprehensive view of the global market for Cannabigerol, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Cannabigerol market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Cannabigerol.
MARKET SEGMENTATION
By Company
- Ilesol Pharmaceuticals
- Biosyyd
- Linnea
- Amyris
- Demetrix
- Avicanna (Aureus Santa Marta)
- Red Mesa Science & Refining, LLC
- Pharma Works LLC (CanniLabs)
- WeeDutch
- Creo Ingredient
- Mile High Labs
- Essentia Pura
- Vantage Hemp
- Verus Extracts
- Extract Labs
- GVB Biopharma
- Klersun, LLC
- Shenzhen Synceres
- Tauto Chem
- Hangzhou Keying Chem
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- CBG Distillate
- CBG lsolate
Segment by Application
- Edibles
- Pharmaceuticals
- Cosmetics
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Cannabigerol manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Cannabigerol sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Cannabigerol sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cannabigerol Product Introduction
1.2 Global Cannabigerol Market Size Forecast
1.2.1 Global Cannabigerol Sales Value (2021–2032)
1.2.2 Global Cannabigerol Sales Volume (2021–2032)
1.2.3 Global Cannabigerol Sales Price (2021–2032)
1.3 Cannabigerol Market Trends & Drivers
1.3.1 Cannabigerol Industry Trends
1.3.2 Cannabigerol Market Drivers & Opportunities
1.3.3 Cannabigerol Market Challenges
1.3.4 Cannabigerol Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cannabigerol Players Revenue Ranking (2025)
2.2 Global Cannabigerol Revenue by Company (2021–2026)
2.3 Global Cannabigerol Sales Volume Ranking of Players (2025)
2.4 Global Cannabigerol Sales Volume by Company (2021–2026)
2.5 Global Cannabigerol Average Price by Company (2021–2026)
2.6 Key Manufacturers Cannabigerol Manufacturing Base and Headquarters
2.7 Key Manufacturers Cannabigerol Product Offerings
2.8 Key Manufacturers Start of Mass Production of Cannabigerol
2.9 Cannabigerol Market Competitive Analysis
2.9.1 Cannabigerol Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Cannabigerol Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cannabigerol revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Cannabigerol Market Classification
3.1 Introduction by Type
3.1.1 CBG Distillate
3.1.2 CBG lsolate
3.1.3 Global Cannabigerol Sales Value by Type
3.1.3.1 Global Cannabigerol Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Cannabigerol Sales Value, by Type (2021–2032)
3.1.3.3 Global Cannabigerol Sales Value, by Type (%), 2021–2032
3.1.4 Global Cannabigerol Sales Volume by Type
3.1.4.1 Global Cannabigerol Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Cannabigerol Sales Volume, by Type (2021–2032)
3.1.4.3 Global Cannabigerol Sales Volume, by Type (%), 2021–2032
3.1.5 Global Cannabigerol Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Edibles
4.1.2 Pharmaceuticals
4.1.3 Cosmetics
4.1.4 Others
4.2 Global Cannabigerol Sales Value by Application
4.2.1 Global Cannabigerol Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Cannabigerol Sales Value, by Application (2021–2032)
4.2.3 Global Cannabigerol Sales Value, by Application (%), 2021–2032
4.3 Global Cannabigerol Sales Volume by Application
4.3.1 Global Cannabigerol Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Cannabigerol Sales Volume, by Application (2021–2032)
4.3.3 Global Cannabigerol Sales Volume, by Application (%), 2021–2032
4.4 Global Cannabigerol Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Cannabigerol Sales Value by Region
5.1.1 Global Cannabigerol Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Cannabigerol Sales Value by Region (2021–2026)
5.1.3 Global Cannabigerol Sales Value by Region (2027–2032)
5.1.4 Global Cannabigerol Sales Value by Region (%), 2021–2032
5.2 Global Cannabigerol Sales Volume by Region
5.2.1 Global Cannabigerol Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Cannabigerol Sales Volume by Region (2021–2026)
5.2.3 Global Cannabigerol Sales Volume by Region (2027–2032)
5.2.4 Global Cannabigerol Sales Volume by Region (%), 2021–2032
5.3 Global Cannabigerol Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Cannabigerol Sales Value, 2021–2032
5.4.2 North America Cannabigerol Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Cannabigerol Sales Value, 2021–2032
5.5.2 Europe Cannabigerol Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Cannabigerol Sales Value, 2021–2032
5.6.2 Asia Pacific Cannabigerol Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Cannabigerol Sales Value, 2021–2032
5.7.2 South America Cannabigerol Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cannabigerol Sales Value, 2021–2032
5.8.2 Middle East & Africa Cannabigerol Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cannabigerol Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Cannabigerol Sales Value and Sales Volume
6.2.1 Key Countries/Regions Cannabigerol Sales Value, 2021–2032
6.2.2 Key Countries/Regions Cannabigerol Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Cannabigerol Sales Value, 2021–2032
6.3.2 United States Cannabigerol Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Cannabigerol Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Cannabigerol Sales Value, 2021–2032
6.4.2 Europe Cannabigerol Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Cannabigerol Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Cannabigerol Sales Value, 2021–2032
6.5.2 China Cannabigerol Sales Value by Type (%), 2025 vs 2032
6.5.3 China Cannabigerol Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Cannabigerol Sales Value, 2021–2032
6.6.2 Japan Cannabigerol Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Cannabigerol Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Cannabigerol Sales Value, 2021–2032
6.7.2 South Korea Cannabigerol Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Cannabigerol Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Cannabigerol Sales Value, 2021–2032
6.8.2 Southeast Asia Cannabigerol Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Cannabigerol Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Cannabigerol Sales Value, 2021–2032
6.9.2 India Cannabigerol Sales Value by Type (%), 2025 vs 2032
6.9.3 India Cannabigerol Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Ilesol Pharmaceuticals
7.1.1 Ilesol Pharmaceuticals Company Information
7.1.2 Ilesol Pharmaceuticals Introduction and Business Overview
7.1.3 Ilesol Pharmaceuticals Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Ilesol Pharmaceuticals Cannabigerol Product Offerings
7.1.5 Ilesol Pharmaceuticals Recent Developments
7.2 Biosyyd
7.2.1 Biosyyd Company Information
7.2.2 Biosyyd Introduction and Business Overview
7.2.3 Biosyyd Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Biosyyd Cannabigerol Product Offerings
7.2.5 Biosyyd Recent Developments
7.3 Linnea
7.3.1 Linnea Company Information
7.3.2 Linnea Introduction and Business Overview
7.3.3 Linnea Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Linnea Cannabigerol Product Offerings
7.3.5 Linnea Recent Developments
7.4 Amyris
7.4.1 Amyris Company Information
7.4.2 Amyris Introduction and Business Overview
7.4.3 Amyris Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Amyris Cannabigerol Product Offerings
7.4.5 Amyris Recent Developments
7.5 Demetrix
7.5.1 Demetrix Company Information
7.5.2 Demetrix Introduction and Business Overview
7.5.3 Demetrix Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Demetrix Cannabigerol Product Offerings
7.5.5 Demetrix Recent Developments
7.6 Avicanna (Aureus Santa Marta)
7.6.1 Avicanna (Aureus Santa Marta) Company Information
7.6.2 Avicanna (Aureus Santa Marta) Introduction and Business Overview
7.6.3 Avicanna (Aureus Santa Marta) Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Avicanna (Aureus Santa Marta) Cannabigerol Product Offerings
7.6.5 Avicanna (Aureus Santa Marta) Recent Developments
7.7 Red Mesa Science & Refining, LLC
7.7.1 Red Mesa Science & Refining, LLC Company Information
7.7.2 Red Mesa Science & Refining, LLC Introduction and Business Overview
7.7.3 Red Mesa Science & Refining, LLC Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Red Mesa Science & Refining, LLC Cannabigerol Product Offerings
7.7.5 Red Mesa Science & Refining, LLC Recent Developments
7.8 Pharma Works LLC (CanniLabs)
7.8.1 Pharma Works LLC (CanniLabs) Company Information
7.8.2 Pharma Works LLC (CanniLabs) Introduction and Business Overview
7.8.3 Pharma Works LLC (CanniLabs) Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Pharma Works LLC (CanniLabs) Cannabigerol Product Offerings
7.8.5 Pharma Works LLC (CanniLabs) Recent Developments
7.9 WeeDutch
7.9.1 WeeDutch Company Information
7.9.2 WeeDutch Introduction and Business Overview
7.9.3 WeeDutch Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 WeeDutch Cannabigerol Product Offerings
7.9.5 WeeDutch Recent Developments
7.10 Creo Ingredient
7.10.1 Creo Ingredient Company Information
7.10.2 Creo Ingredient Introduction and Business Overview
7.10.3 Creo Ingredient Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Creo Ingredient Cannabigerol Product Offerings
7.10.5 Creo Ingredient Recent Developments
7.11 Mile High Labs
7.11.1 Mile High Labs Company Information
7.11.2 Mile High Labs Introduction and Business Overview
7.11.3 Mile High Labs Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Mile High Labs Cannabigerol Product Offerings
7.11.5 Mile High Labs Recent Developments
7.12 Essentia Pura
7.12.1 Essentia Pura Company Information
7.12.2 Essentia Pura Introduction and Business Overview
7.12.3 Essentia Pura Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Essentia Pura Cannabigerol Product Offerings
7.12.5 Essentia Pura Recent Developments
7.13 Vantage Hemp
7.13.1 Vantage Hemp Company Information
7.13.2 Vantage Hemp Introduction and Business Overview
7.13.3 Vantage Hemp Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Vantage Hemp Cannabigerol Product Offerings
7.13.5 Vantage Hemp Recent Developments
7.14 Verus Extracts
7.14.1 Verus Extracts Company Information
7.14.2 Verus Extracts Introduction and Business Overview
7.14.3 Verus Extracts Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Verus Extracts Cannabigerol Product Offerings
7.14.5 Verus Extracts Recent Developments
7.15 Extract Labs
7.15.1 Extract Labs Company Information
7.15.2 Extract Labs Introduction and Business Overview
7.15.3 Extract Labs Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Extract Labs Cannabigerol Product Offerings
7.15.5 Extract Labs Recent Developments
7.16 GVB Biopharma
7.16.1 GVB Biopharma Company Information
7.16.2 GVB Biopharma Introduction and Business Overview
7.16.3 GVB Biopharma Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 GVB Biopharma Cannabigerol Product Offerings
7.16.5 GVB Biopharma Recent Developments
7.17 Klersun, LLC
7.17.1 Klersun, LLC Company Information
7.17.2 Klersun, LLC Introduction and Business Overview
7.17.3 Klersun, LLC Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Klersun, LLC Cannabigerol Product Offerings
7.17.5 Klersun, LLC Recent Developments
7.18 Shenzhen Synceres
7.18.1 Shenzhen Synceres Company Information
7.18.2 Shenzhen Synceres Introduction and Business Overview
7.18.3 Shenzhen Synceres Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Shenzhen Synceres Cannabigerol Product Offerings
7.18.5 Shenzhen Synceres Recent Developments
7.19 Tauto Chem
7.19.1 Tauto Chem Company Information
7.19.2 Tauto Chem Introduction and Business Overview
7.19.3 Tauto Chem Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 Tauto Chem Cannabigerol Product Offerings
7.19.5 Tauto Chem Recent Developments
7.20 Hangzhou Keying Chem
7.20.1 Hangzhou Keying Chem Company Information
7.20.2 Hangzhou Keying Chem Introduction and Business Overview
7.20.3 Hangzhou Keying Chem Cannabigerol Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Hangzhou Keying Chem Cannabigerol Product Offerings
7.20.5 Hangzhou Keying Chem Recent Developments
8 Industry Chain Analysis
8.1 Cannabigerol Industrial Chain
8.2 Cannabigerol Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Cannabigerol Sales Model
8.5.2 Sales Channels
8.5.3 Cannabigerol Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Cannabigerol Market Trends
Table 2. Cannabigerol Market Drivers & Opportunities
Table 3. Cannabigerol Market Challenges
Table 4. Cannabigerol Market Restraints
List of Figures
Figure 1. Cannabigerol Product Picture
Figure 2. Global Cannabigerol Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 4. Global Cannabigerol Sales Volume (Tons), 2021–2032
Figure 5. Global Cannabigerol Sales Price (US$/kg), 2021–2032
Figure 6. Cannabigerol Report Years Considered
Figure 7. Global Cannabigerol Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Cannabigerol Sales Volume Ranking of Players (Tons), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cannabigerol Revenue in 2025
Figure 10. Cannabigerol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. CBG Distillate Picture
Figure 12. CBG lsolate Picture
Figure 13. Global Cannabigerol Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Cannabigerol Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Cannabigerol Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
Figure 16. Global Cannabigerol Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Cannabigerol Price by Type (US$/kg), 2021–2032
Figure 18. Product Picture of Edibles
Figure 19. Product Picture of Pharmaceuticals
Figure 20. Product Picture of Cosmetics
Figure 21. Product Picture of Others
Figure 22. Global Cannabigerol Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Cannabigerol Sales Value Market Share by Application, 2025 & 2032
Figure 24. Global Cannabigerol Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
Figure 25. Global Cannabigerol Sales Volume Market Share by Application, 2025 & 2032
Figure 26. Global Cannabigerol Price by Application (US$/kg), 2021–2032
Figure 27. North America Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 28. North America Cannabigerol Sales Value by Country (%), 2025 vs 2032
Figure 29. Europe Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 30. Europe Cannabigerol Sales Value by Country (%), 2025 vs 2032
Figure 31. Asia Pacific Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 32. Asia Pacific Cannabigerol Sales Value by Region (%), 2025 vs 2032
Figure 33. South America Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 34. South America Cannabigerol Sales Value by Country (%), 2025 vs 2032
Figure 35. Middle East & Africa Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 36. Middle East & Africa Cannabigerol Sales Value by Country (%), 2025 vs 2032
Figure 37. Key Countries/Regions Cannabigerol Sales Value (%), 2021–2032
Figure 38. Key Countries/Regions Cannabigerol Sales Volume (%), 2021–2032
Figure 39. United States Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 40. United States Cannabigerol Sales Value by Type (%), 2025 vs 2032
Figure 41. United States Cannabigerol Sales Value by Application (%), 2025 vs 2032
Figure 42. Europe Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 43. Europe Cannabigerol Sales Value by Type (%), 2025 vs 2032
Figure 44. Europe Cannabigerol Sales Value by Application (%), 2025 vs 2032
Figure 45. China Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 46. China Cannabigerol Sales Value by Type (%), 2025 vs 2032
Figure 47. China Cannabigerol Sales Value by Application (%), 2025 vs 2032
Figure 48. Japan Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 49. Japan Cannabigerol Sales Value by Type (%), 2025 vs 2032
Figure 50. Japan Cannabigerol Sales Value by Application (%), 2025 vs 2032
Figure 51. South Korea Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 52. South Korea Cannabigerol Sales Value by Type (%), 2025 vs 2032
Figure 53. South Korea Cannabigerol Sales Value by Application (%), 2025 vs 2032
Figure 54. Southeast Asia Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 55. Southeast Asia Cannabigerol Sales Value by Type (%), 2025 vs 2032
Figure 56. Southeast Asia Cannabigerol Sales Value by Application (%), 2025 vs 2032
Figure 57. India Cannabigerol Sales Value (US$ Million), 2021–2032
Figure 58. India Cannabigerol Sales Value by Type (%), 2025 vs 2032
Figure 59. India Cannabigerol Sales Value by Application (%), 2025 vs 2032
Figure 60. Cannabigerol Industrial Chain
Figure 61. Cannabigerol Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cannabigerol market?
The top companies in the global Cannabigerol market are Ilesol Pharmaceuticals、Biosyyd、Linnea.
Which region is expected to have the highest market share?
What was the global market size of Cannabigerol in 2032?
What is the annual compound growth rate of the global Cannabigerol market size from 2026 to 2032?
What was the global market size of Cannabigerol in 2026?
Related Reports
Global Cannabigerol Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 292 million by 2032, at a CAGR of 8.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 178
USD 4900.00
(Single User License)
Global Cannabigerol Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cannabigerol market size was US$ 164 million in 2025 and is forecast to reach a readjusted size of US$ 292 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 107
USD 4250.00
(Single User License)
Global Cannabigerol Market Research Report 2026
The global Cannabigerol market was valued at US$ 164 million in 2025 and is anticipated to reach US$ 292 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 147
USD 2900.00
(Single User License)
Global Cannabigerol Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cannabigerol market is projected to grow from US$ 157 million in 2024 to US$ 271 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 179
USD 4900.00
(Single User License)
Global Cannabigerol Market Insights, Forecast to 2031
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 271 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published Date: 2025-06-28
Pages: 180
USD 4900.00
(Single User License)
Global Cannabigerol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cannabigerol market size was US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-06-28
Pages: 108
USD 4250.00
(Single User License)
Cannabigerol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cannabigerol was estimated to be worth US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-06-28
Pages: 146
USD 3950.00
(Single User License)
Global Cannabigerol Market Research Report 2025
The global market for Cannabigerol was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 271 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published Date: 2025-06-28
Pages: 107
USD 2900.00
(Single User License)
Global Cannabigerol Market Insights, Forecast to 2030
The global Cannabigerol market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-11-12
Pages: 176
USD 4900.00
(Single User License)
Global and United States Cannabigerol Market Report & Forecast 2024-2030
The global Cannabigerol revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-11-12
Pages: 144
USD 4350.00
(Single User License)
Global Cannabigerol Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 292 million by 2032, at a CAGR of 8.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 178
USD 4900.00 (Single User License)Global Cannabigerol Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cannabigerol market size was US$ 164 million in 2025 and is forecast to reach a readjusted size of US$ 292 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 107
USD 4250.00 (Single User License)Global Cannabigerol Market Research Report 2026
The global Cannabigerol market was valued at US$ 164 million in 2025 and is anticipated to reach US$ 292 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 147
USD 2900.00 (Single User License)Global Cannabigerol Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cannabigerol market is projected to grow from US$ 157 million in 2024 to US$ 271 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 179
USD 4900.00 (Single User License)Global Cannabigerol Market Insights, Forecast to 2031
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 271 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published: 2025-06-28
Pages: 180
USD 4900.00 (Single User License)Global Cannabigerol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cannabigerol market size was US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-06-28
Pages: 108
USD 4250.00 (Single User License)Cannabigerol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cannabigerol was estimated to be worth US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-06-28
Pages: 146
USD 3950.00 (Single User License)Global Cannabigerol Market Research Report 2025
The global market for Cannabigerol was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 271 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published: 2025-06-28
Pages: 107
USD 2900.00 (Single User License)Global Cannabigerol Market Insights, Forecast to 2030
The global Cannabigerol market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-11-12
Pages: 176
USD 4900.00 (Single User License)Global and United States Cannabigerol Market Report & Forecast 2024-2030
The global Cannabigerol revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-11-12
Pages: 144
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now